Schalop Lee Troy bought LTRN
May 12, 2026 · Form 4 insider transaction
Schalop Lee Troy bought 48,544 shares of Lantern Pharma Inc. at $2.06 per share, a transaction worth $100.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
48,544
Price
$2.06
Total value
$100.0K
InsiderSchalop Lee Troy
Role—
CompanyLantern Pharma Inc. (LTRN)
SecurityCommon stock, $0.001 par value
Transaction codeP: Open-market purchase
Transaction dateMay 12, 2026
Filing dateMay 14, 2026
Shares owned after48,544
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were acquired in the issuer's offering of securities that closed on May 14, 2026. The warrants are exercisable commencing on November 14, 2026.